These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 7383883

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Malignant adrenocortical tumor. A propos of a case].
    Boujnah H, Ben Ayed H, Ayed M, Zmerli S.
    J Urol (Paris); 1982; 88(9):615-8. PubMed ID: 7169550
    [Abstract] [Full Text] [Related]

  • 27. [Mitotane in the treatment of adrenal carcinoma].
    Sane T.
    Duodecim; 2010; 126(17):2040-6. PubMed ID: 21053521
    [Abstract] [Full Text] [Related]

  • 28. [Hepatotoxicity of a synthetic cortisol antagonist: OP'DDD (mitotane)].
    Neuman O, Bruckert E, Chadarevian R, Jacob N, Turpin G.
    Therapie; 2001; 56(6):793-7. PubMed ID: 11878112
    [Abstract] [Full Text] [Related]

  • 29. Cis-platinum treatment of metastatic adrenal carcinoma.
    Tattersall MH, Lander H, Bain B, Stocks AE, Woods RL, Fox RM, Byrne E, Trotten JR, Roos I.
    Med J Aust; 1980 May 03; 1(9):419-21. PubMed ID: 7190216
    [Abstract] [Full Text] [Related]

  • 30. [Therapy of Cushing's syndrome].
    Müller OA.
    Dtsch Med Wochenschr; 1985 Dec 06; 110(49):1900-2. PubMed ID: 2998722
    [No Abstract] [Full Text] [Related]

  • 31. [Case report on metastasis surgery in adrenal cortex cancer].
    Buchholz NP, Süberli H, Ausfeld R.
    Urologe A; 1992 Jan 06; 31(1):14-8. PubMed ID: 1553798
    [Abstract] [Full Text] [Related]

  • 32. [Cancer of the adrenal cortex treated by O,P"-DDD (author's transl)].
    Van Geertruyden J, De Myttenaere M, Corvilain J.
    Acta Chir Belg; 1980 Jan 06; 79(4):299-302. PubMed ID: 7468032
    [Abstract] [Full Text] [Related]

  • 33. Cortisol as a possible marker of metastatic adrenocortical carcinoma: a case report with 3-year follow-up.
    Schwarte S, Brabant EG, Bastian L, Bruns F.
    Anticancer Res; 2007 Jan 06; 27(4A):1917-20. PubMed ID: 17649795
    [Abstract] [Full Text] [Related]

  • 34. Cytotoxic chemotherapy in adrenal cortical carcinoma.
    Haq MM, Legha SS, Samaan NA, Bodey GP, Burgess MA.
    Cancer Treat Rep; 1980 Jan 06; 64(8-9):909-13. PubMed ID: 7448828
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Associated role of surgery and antimitotic o, p'-DDD treatment in hyperfunctioning adrenal cancers with diffuse metastases].
    Perigli G, Borrelli D, Salvatore S, Cicchi P, Burci P.
    Chir Ital; 1981 Feb 06; 33(1):122-34. PubMed ID: 6167374
    [Abstract] [Full Text] [Related]

  • 37. [State of the skin in Itsenko-Cushing disease and hormonally active tumors of the adrenal cortex before and after treatment with chloditan].
    Mikhaĭlenko TI, Komissarenko IV.
    Vestn Dermatol Venerol; 1982 Aug 06; (8):64-6. PubMed ID: 7148138
    [No Abstract] [Full Text] [Related]

  • 38. [Use of mitotane (o,p'-DDD) in adrenal cortex hyperfunction].
    Kasperlik-Załuska A, Migdalska B.
    Endokrynol Pol; 1982 Aug 06; 33(1-3):99-104. PubMed ID: 7183447
    [No Abstract] [Full Text] [Related]

  • 39. Metastatic adrenal cortical carcinoma. Documented cure with combined chemotherapy.
    Ostuni JA, Roginsky MS.
    Arch Intern Med; 1975 Sep 06; 135(9):1257-8. PubMed ID: 1164127
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.